Michael John Reed

This inventor holds 59 USPTO granted patents and 2 published patent applications and 5 EPO patents, primarily in Steroid Inhibitors (CPC class 5141). Top assignees: Sterix Limited, Imperial College of Science, Technology and Medicine, Schering Aktiengesellschaft. Active years: 1994-2013.

USPTO Granted Patents = 59 (Patent Applications = 2)

% Patents Active = 40.7

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 289(Granted Patents)

Forward Citations (Not Self Cited) = 204(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Berksire, GB (2007)
The Oxford Science Park, GB (2003 - 2008)
London, GB (1994 - 2010)
Oxford, GB (2006 - 2010)
The Oxford Science Parl, GB (2011)
Northamptonshire, GB (2012)
Slough, GB (2010 - 2013)

Company Filing History:

Imperial College of Science, Technology and Medicine

patents

1 out of 1,409

Schering Aktiengesellschaft

patents

4. 1 out of 343

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

patents

5. 3 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2013

Loading Chart...

Areas of Expertise:

Aromatase Inhibitors

Steroid Sulphatase

Endocrine Tumors

Heterocyclic Compounds

Thioether Sulphamate

11β-Hydroxysteroid

Oestrogen Derivatives

Interleukin-6 Antagonists

Polycyclic Sulphamate

Pharmaceutical Composition

17beta-HSD3 Inhibitors

4-triazol-1-yl Derivatives

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8470860 - Phenyl-sulfamates as aromatase inhibitors (2013-06-25),

2. 8394825 - Compound (2013-03-12),

3. D672512 - Animal collar (2012-12-11),

4. 8207152 - Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling (2012-06-26),

5. 8148415 - Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity (2012-04-03),

6. 8124614 - Steroidal compounds for inhibiting steroid sulphatase (2012-02-28),

7. 8119627 - Heterocyclic compounds as inhibitors of 17beta-HSD3 (2012-02-21),

8. 8093279 - Compound (2012-01-10),

9. 8030296 - Oestrogen-17-sulphamates as inhibitors of steroid sulphatase (2011-10-04),

10. 8022224 - 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors (2011-09-20),

11. 8003783 - 17B-hydroxysteroid dehydrogenase inhibitors (2011-08-23),

12. 7968561 - Steroidal compounds as steroid sulphatase inhibitors (2011-06-28),

13. 7893284 - Oestrogen derivatives as inhibitors of steroid sulphatase (2011-02-22),

14. 7846965 - Compound (2010-12-07),

15. 7786152 - Compound (2010-08-31),

Title: The Inventor Michael John Reed

Introduction: Michael John Reed is a renowned inventor based in Slough, United Kingdom, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Michael John Reed holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of interests and expertise.

Career Highlights: Throughout his career, Michael John Reed has been recognized for his ability to transform complex ideas into practical solutions, earning him a reputation as a visionary inventor. His inventions have significantly impacted industries such as robotics, biotechnology, and environmental conservation.

Collaborations: Michael John Reed has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement his inventions. His collaborative efforts have resulted in the successful commercialization of several groundbreaking technologies.

Conclusion: In conclusion, Michael John Reed's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to creating impactful solutions continues to inspire future generations of inventors and innovators.